Charter Oak Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Charter Oak Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,509	Closed	-$270K	–	256
2022 Q2	$270K	Hold	3,509	–	–	0.04%	153
2022 Q1	$256K	Buy	3,509 +401	+13%	+$26.9K	0.03%	162
2021 Q4	$194K	Buy	3,108 +62	+2%	+$3.64K	0.02%	183
2021 Q3	$180K	Hold	3,046	–	–	0.02%	183
2021 Q2	$204K	Sell	3,046 -98	-3%	-$6.39K	0.03%	167
2021 Q1	$198K	Sell	3,144 -204	-6%	-$12.7K	0.03%	169
2020 Q4	$208K	Buy	+3,348	New	+$206K	0.03%	156

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charter Oak Capital Management's BMY Position: Q3 2022 in Review

Charter Oak Capital Management sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 3,509 shares — an estimated $270K sold.

Charter Oak Capital Management first reported a position in BMY in Q4 2020 and held it in 7 quarters. The position peaked at $270K in Q2 2022. 2,469 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

Charter Oak Capital Management reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
Charter Oak Capital Management sold 3,509 Bristol-Myers Squibb shares in Q3 2022, an estimated $270K.
Charter Oak Capital Management first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 7 quarters.
Charter Oak Capital Management's Bristol-Myers Squibb position peaked at $270K in Q2 2022.
2,469 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on Charter Oak Capital Management's 13F filing for Q3 2022, filed 6 Dec 2022.